Pipeline
Pipeline
Treating infections, avoiding surgery.
Not a new molecule. A new way to get proven antibiotics into the infections that standard care leaves behind.
AURA is an investigational product and is not approved for use in any country. Timelines are plans, not commitments.
By indication
One platform. Six indications.
- Chronic woundsEstimated approval 2030Halfway through IND/CTA-enabling
- Hidradenitis suppurativaStarting IND/CTA-enabling
- CellulitisStarting IND/CTA-enabling
- AcneHalfway through preclinical proof of concept
- Prosthetic joint infectionsHalfway through preclinical proof of concept
- Solid tumoursStarting preclinical proof of concept